
Telque-CL 5mg/40mg Tablet
Marketer
Tms India Pvt Ltd
Salt Composition
Cilnidipine (5mg) + Telmisartan (40mg)
Overview Telque-CL 5mg/40mg Tablet
Cardio-Dual 5mg/40mg tablets combine two active ingredients to effectively manage hypertension. This dual-action formulation reduces blood pressure by vasodilation, easing the workload on the heart and improving circulation. This lowers the risk of cardiovascular events such as stroke and myocardial infarction. Cardio-Dual 5mg/40mg can be administered with or without food, but consistent daily dosing at the prescribed time is crucial for optimal efficacy. Dosage is individualized based on your health status and response to treatment. Continued use is vital, even with symptom improvement, as it maintains blood pressure control and reduces long-term risks. Lifestyle modifications, such as regular physical activity, smoking cessation, and a diet low in sodium and fat, enhance the medication's effectiveness. Commonly reported side effects include peripheral edema, headache, somnolence, vertigo, fatigue, altered taste perception, and gastrointestinal upset. Drowsiness may occur; avoid activities requiring alertness until its effects are known. Report any persistent or bothersome side effects to your physician. Prior to commencing treatment, inform your doctor of any pre-existing renal or hepatic impairment, or severe dehydration. Consult your physician before use if pregnant or breastfeeding. Regular blood pressure monitoring and periodic kidney function assessments are necessary during treatment.
Primary Ingredients of Telque-CL 5mg/40mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Telque-CL 5mg/40mg Tablet
Managing Elevated Blood Pressure
Major Benefits of Telque-CL 5mg/40mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telque-CL 5mg/40mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Telque-CL 5mg/40mg Tablet:
- Ankle swelling
- Headache
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Dizziness
- Tiredness
- Palpitations
- Upset stomach
- Increased potassium level in blood
- Cardiogenic shock
How to use Telque-CL 5mg/40mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. Telque-CL 5mg/40mg Tablets can be consumed with or without food; however, consistent timing is recommended for optimal results.
How Telque-CL 5mg/40mg Tablet works:
Each Telque-CL 5mg/40mg tablet combines Cilnidipine, a calcium channel blocker, with Telmisartan, an angiotensin receptor blocker, to achieve effective blood pressure reduction. This dual action relaxes blood vessels and enhances the heart's pumping efficiency, thereby lowering blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Telque-CL 5mg/40mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Telque-CL 5mg/40mg tablets during pregnancy poses a confirmed risk to fetal development, making it inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Telque-CL 5mg/40mg tablets while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving should be avoided if you experience drowsiness, dizziness, blurred vision, or reduced alertness after taking a Telque-CL 5mg/40mg tablet. These side effects are possible.
KidneyCONSULT YOUR DOCTOR
Data on Telque-CL 5mg/40mg Tablet use in individuals with renal impairment is scarce. Seek your physician's advice.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Telque-CL 5mg/40mg tablets, potentially requiring dosage modification. Medical advice is recommended. Telque-CL 5mg/40mg tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Telque-CL 5mg/40mg Tablet :
Should you forget a Telque-CL 5mg/40mg Tablet dose, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telque-CL 5mg/40mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
